BCHC joins call to fund advanced disease detection
April 2026
BCHC joined a coalition of public health, scientific, and clinical organizations to urge Congressional appropriations leaders to provide $175 million in FY27 for the CDC’s Advanced Molecular Detection (AMD) program.
Established in 2014, AMD uses cutting-edge genomic sequencing and data analytics to help local and state health departments rapidly detect, track, and respond to infectious disease threats. AMD has been instrumental in everything from containing foodborne outbreaks to monitoring novel influenza strains like H5N1.
The program is critically underfunded relative to its role. AMD currently receives just $43 million annually, and supplemental funds that have sustained expanded capabilities – including five regional Pathogen Genomics Centers of Excellence – are projected to run out in FY27.
Without a significant increase in base funding, the U.S. risks losing genomic surveillance infrastructure that took years to build, along with the trained workforce and academic partnerships that make it effective.
